|
From
•>>March 2005
Richard M. Caprioli
answers
a few questions about this month's fast moving front in the
field of Clinical Medicine.
Field: Clinical Medicine
Article: Imaging mass spectrometry: A new technology for the analysis of protein expression in mammalian tissues
Author: Stoeckli, M;Chaurand, P;Hallahan,
DE;Caprioli, RM
Journal: NATURE MED, 7: (4) 493-496, APR 2001
Addresses:
Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37212 USA.
Vanderbilt Univ, Sch Med, Mass Spectrometry Res Ctr, Nashville, TN 37212 USA.
 |
| • |
July
1, 2006:
This paper has also been named the Fast Moving Front
paper in Clinical Medicine for July
2006. |
|
|

Why do you think your paper is highly cited?
|
“The technology allows the scientist to take molecular pictures of proteins in biopsy tissue taken from patients with a variety of diseases” |
|
The technology highlighted brings a new dimension to
molecular analysis of tissues, allowing large molecules such as
proteins to be imaged on tissue surfaces. One can produce, from
a simple raster of the laser on the tissue, hundreds of
molecularly specific images with spatial resolution in the
low-micron range. The technology is a superb discovery tool,
enabling molecular spatial analysis and relative quantitation
without the use of antibodies or other chemical recognition
agents.
Does it describe a new discovery or new methodology that's
useful to others?
The technology involves modification of existing mass
spectrometry instrumentation, MALDI MS, along with sample
preparation protocols specifically created for tissue section
analysis. Therefore, those who have the basic instrumentation
can install, relatively inexpensively, the required
modifications and obtain software to perform imaging. Our
version of this software is available as freeware for those
using similar instruments. The applicability is very wide,
basically encompassing.
Could you summarize the significance of your paper in
layman's terms?
The technology allows the scientist to take molecular
pictures of proteins in biopsy tissue taken from patients with a
variety of diseases. This is important in helping identify the
disease, determining how advanced and how aggressive the disease
is, and helping the clinician assess the correct treatment for
that individual patient’s needs.
How did you become involved in this research?
In my interest in protein distribution in both normal and diseased tissue, there was a critical need for new ways to observe molecular events in tissues that were molecularly specific and at the same time measured many hundreds of proteins simultaneously. Mass spectrometry was clearly the best candidate technology to do
this.
Richard M. Caprioli, Ph.D.
Stanley Cohen Professor of Biochemistry
Director of the Mass Spectrometry Research Center
Vanderbilt University School of Medicine
Nashville, TN, USA
|
Return to Fast Moving Fronts |
Return to Special Topics main menu
|